Guinea pigs mechanically hyperventilated with dry gas exhibit hyperpne
a-induced bronchoconstriction (HIB) and hyperpnea-induced bronchovascu
lar hyperpermeability (HIBVH). Tachykinins released from airway C-fibe
r neurons are the central mediators of guinea pig HIB but play only a
contributory role in HIBVH. Recent studies suggest that eicosanoid med
iators can provoke bronchoconstriction and bronchovascular hyperpermea
bility, are released by dry gas hyperpnea, and can themselves elicit o
r modulate tachykinin release. We therefore hypothesized that eicosano
ids may participate in HIB and/or HIBVH. To test these hypotheses, we
analyzed respiratory system resistance changes and Evans blue-labeled
albumin extravasation into the airways of 60 tracheostomized and mecha
nically ventilated guinea pigs. Animals were subjected to 10 min of is
ocapnic dry gas hyperpnea or to quiet breathing of humidified gas and
received as pretreatment either piroxicam, a cyclooxygenase (CO) inhib
itor; A-63162, a 5-lipoxygenase (5-LO) inhibitor; BW-755c, a combined
CO and 5-LO inhibitor; ICI-198,615, a leukotriene D-4 receptor antagon
ist; or no drug. HIB was substantially (50-80%) reduced by each of the
four eicosanoid-modulating drugs. In contrast, HIBVH was reduced only
by BW-755c, and this effect occurred only within the extrapulmonary a
irways (42% reduction). These data indicate that both CO and 5-LO prod
ucts, including leukotriene D-4, participate in the pathogenesis of HI
B but that, like tachykinins, they play only a small contributory role
in HIBVH. Together with our previous demonstration that sensory neuro
peptide release is critical for the occurrence of HIB, we conclude tha
t the roles of eicosanoids and tachykinins in guinea pig HIB are inter
dependent.